Recent Advances and Challenges in Cancer Care, with a Focus on Multiple Myeloma, Lymphoma, and Lung Cancer: Key Insights from the Onco Summit 2024-The APAC Chapter.

Q2 Medicine

Asian Pacific Journal of Cancer Prevention Pub Date : 2025-05-01 DOI:10.31557/APJCP.2025.26.5.1543

Ja Min Byun, Won Seog Kim, Myung-Ju Ahn

{"title":"Recent Advances and Challenges in Cancer Care, with a Focus on Multiple Myeloma, Lymphoma, and Lung Cancer: Key Insights from the Onco Summit 2024-The APAC Chapter.","authors":"Ja Min Byun, Won Seog Kim, Myung-Ju Ahn","doi":"10.31557/APJCP.2025.26.5.1543","DOIUrl":null,"url":null,"abstract":"<p><p>The Onco Summit 2024: The APAC Chapter took place over 2 days, between 16th and 17th February 2024, in South Korea. The event aimed to provide healthcare professionals with the latest updates in different oncology disciplines and share best practices and strategies to ensure optimal patient care. The Summit aimed to foster international and local collaborations to address challenges, understand the future of oncology, and explore opportunities to improve cancer care, especially in the Asia Pacific region. There were 27 scientific presentations and 10 panel discussions with engaging discussions around recent diagnostic and therapeutic advances in cancer care and associated challenges. More than 150 oncology specialists from 11 countries attended the Summit. The Summit highlighted specific challenges in the Asia Pacific region and discussed transferrable strategies to address some of these challenges. This report aims to present a summary of key discussions from the Summit for the global and Asia Pacific oncology community.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"26 5","pages":"1543-1551"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2025.26.5.1543","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

The Onco Summit 2024: The APAC Chapter took place over 2 days, between 16th and 17th February 2024, in South Korea. The event aimed to provide healthcare professionals with the latest updates in different oncology disciplines and share best practices and strategies to ensure optimal patient care. The Summit aimed to foster international and local collaborations to address challenges, understand the future of oncology, and explore opportunities to improve cancer care, especially in the Asia Pacific region. There were 27 scientific presentations and 10 panel discussions with engaging discussions around recent diagnostic and therapeutic advances in cancer care and associated challenges. More than 150 oncology specialists from 11 countries attended the Summit. The Summit highlighted specific challenges in the Asia Pacific region and discussed transferrable strategies to address some of these challenges. This report aims to present a summary of key discussions from the Summit for the global and Asia Pacific oncology community.

查看原文本刊更多论文

癌症治疗的最新进展和挑战，重点是多发性骨髓瘤、淋巴瘤和肺癌：来自Onco峰会2024-亚太分会的关键见解。

2024年Onco峰会：亚太分会于2024年2月16日至17日在韩国举行，为期两天。该活动旨在为医疗保健专业人员提供不同肿瘤学学科的最新进展，并分享最佳实践和策略，以确保最佳的患者护理。峰会旨在促进国际和本地合作，以应对挑战，了解肿瘤学的未来，并探索改善癌症护理的机会，特别是在亚太地区。有27个科学报告和10个小组讨论，围绕癌症护理的最新诊断和治疗进展以及相关挑战进行了积极的讨论。来自11个国家的150多名肿瘤学专家参加了峰会。首脑会议强调了亚太地区的具体挑战，并讨论了应对其中一些挑战的可转移战略。本报告旨在为全球和亚太肿瘤学界提供峰会主要讨论的摘要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asian Pacific Journal of Cancer Prevention 医学-肿瘤学

CiteScore

2.80

自引率

0.00%

发文量

779

审稿时长

3 months

期刊介绍： Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation. The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally. The APJCP publishes original research results under the following categories: -Epidemiology, detection and screening. -Cellular research and bio-markers. -Identification of bio-targets and agents with novel mechanisms of action. -Optimal clinical use of existing anti-cancer agents, including combination therapies. -Radiation and surgery. -Palliative care. -Patient adherence, quality of life, satisfaction. -Health economic evaluations.